of airway inflammatory cells (8); the novelty of our study lies in the inclusion of flow cytometric data and the application of stereology to the field of alveolar epithelial regeneration.
Dynamic intrinsic positive end-expiratory pressure (PEEPi) plays an important pathophysiological role in many acute and chronic respiratory diseases. A substantial amount of energy is expended in decompressing gas to overcome it and start inspiration, both in spontaneous breathing and during assisted mechanical ventilation (MV) (1, 2) . It is important to set the external PEEP correctly during MV to reduce the inspiratory effort required to trigger the ventilator and to avoid further hyperinflation. PEEPi also adversely affects hemodynamics, predisposes to patient-ventilator asynchrony, increases the work of breathing, Author Contributions: Conception, design, analysis and interpretation, and drafting of the manuscript: E.B., L.P., L.A., and S.N. Design, analysis, and interpretation: L.F., V.C., and E.P. Analysis and interpretation: G.L., G.C., and F.T. causes dyspnea, and makes interpretation of hemodynamic and respiratory system mechanics data more difficult.
Unfortunately, PEEPi is measured using a minimally invasive, sophisticated method based on esophageal manometry (3), which is difficult to apply in everyday clinical practice.
In this physiological investigation, we assessed for the first time the possibility of recording PEEPi noninvasively (Clinicaltrials.gov identifier, NCT 02388282). Some of the results of these studies have been reported previously in the form of an abstract (4).
Methods
Ultrasonography recordings of PEEPi (PEEPi ECHO ) were compared with those obtained using the transdiaphragmatic pressure (PEEPi Pdi ). PEEPi Pdi was recorded as previously described, using the balloon-catheter technique, and airflow was recorded using a pneumotachograph connected to a mouthpiece (3). Twelve patients who were recovering from an acute exacerbation of hypercapnic respiratory failure underwent ultrasonography via a high-frequency linear probe placed in the midaxillary line over the 6th to 10th intercostal space using a customized machine (MyLab Gamma; Esaote). Recordings were made with patients in a semirecumbent position. The zone of apposition was assessed 0.5-2 cm below the costophrenic sinus. Once the desired window in B-mode was obtained, the modality was switched to M-mode to visualize the diaphragm better. It was visible as two parallel hyperechoic lines that diverged during inspiration. The flow and Pdi traces were fed into an Echo-Doppler machine. To test the hypothesis that a subtle change from a linear to a granular pattern at the diaphragm-liver interface was due to the start of diaphragm contraction, as assessed using the Pdi trace, we measured the time latency (in milliseconds) between the onset of diaphragm contraction on ultrasound and the onset of inspiratory flow (T LAT,US ) and the time latency (in milliseconds) from the onset of the rise in Pdi from baseline to the onset of inspiratory flow (T LAT,Pdi ). We then assessed the presence of PEEPi using the following equation: PEEPi ECHO = P0.1 M 3 (T LAT,US /100). P0.1 M is the mouth occlusion pressure at 100 ms, an estimate of the effort a patient must make to generate the inspiratory flow. It was measured using a unidirectional valve, occluded during expiration so that the P0.1 M was measured from the FRC as previously described (5) .
Individual data were obtained from a mean 6 SD of five breaths obtained under different conditions (different levels of support during MV or before/after bronchodilation). T LAT,US and T LAT,Pdi were analyzed by two independent operators. T LAT,US was calculated several days later using a computerized program, so that the bias of measurement would be minimized. T LAT,US Definition of abbreviations: ALS = amyotrophic lateral sclerosis; COPD = chronic obstructive pulmonary disease; ETI = endotracheal intubation; ext PEEP = external positive end-expiratory pressure; LAMA = long-acting muscarinic antagonist; NIV = noninvasive mechanical ventilation; P0.1 M = mouth occlusion pressure at 100 ms; P0.1 Pes = esophageal occlusion pressure at 100 ms; PEEPi ECHO = positive end-expiratory pressure recorded using ultrasonography; PEEPi Pdi = positive end-expiratory pressure recorded using the transdiaphragmatic pressure; PS = pressure support (cm H 2 O); PSP = progressive supranuclear palsy; SABA = short-acting b 2 -agonist; SB = spontaneous breathing.
versus T LAT,Pdi and PEEPi ECHO versus PEEPi Pdi measurements were assessed with linear mixed effect models (6) and the Bland-Altman (7) method for assessing agreement between measurements using two techniques.
Results
Twenty-nine trials were analyzed in 11 of 12 patients (one individual could not hold the mouthpiece firmly), for a total of 145 measurements. Figures 1A and 1B Figure 1C represents the correlation between PEEPi Pdi and PEEPi ECHO (r = 0.75; P , 0.001; 95% CI, 0.4-0.9; slope = 0.9; intercept = 20.02), and Figure 1D is the Bland-Altman plot (bias = 20.3; upper level of agreement = 1.5; lower level of agreement = 22.0). Using a threshold value of >2 cm H 2 O to define a significant PEEPi, we were able to identify a significant PEEPi correctly in 24 of 29 trials, with a sensitivity of 100% and a specificity of 74%. Finally, the ultrasound measure of T LAT showed a high interoperator concordance (bias = 20.5; upper level of agreement = 20 ms; lower level of agreement = 221 ms; interclass correlation coefficient = 0.98; 95% CI, 0.97-0.99).
Discussion
Esophageal pressure measurements obtained by the ballooncatheter technique can be used to identify the presence and amount of PEEPi in a spontaneously breathing patient. This makes it easier to choose the most appropriate ventilator settings and thereby optimally reduce the work of breathing. However, this procedure is not well tolerated in a consistent portion of patients and requires dedicated equipment. For these reasons, it is rarely used routinely in clinical practice.
Previous studies have reported the feasibility and accuracy of bedside ultrasound to evaluate the thickness and function of the diaphragm, and their contribution to the respiratory workload (8) . In this preliminary physiological investigation, we have for the first time demonstrated that the recording of PEEPi by ultrasound is feasible and correlates well with the gold standard evaluation technique (i.e., PEEPi Pdi ).
Limitations. In patients with chronic obstructive pulmonary disease (COPD) and PEEPi, there is an important time delay between the onset of inspiration at the alveolar level (i.e., the initial negative deflection in esophageal pressure) and the beginning of airflow at the airway opening. This is particularly an issue during unassisted breathing (9) . Five out of 12 of our patients were breathing spontaneously, and in this population Murciano and colleagues (10) showed a discrepancy between mouth and esophageal occlusion pressures in patients with acute respiratory failure. However, Marazzini and colleagues (11) showed that in stable patients with COPD, a difference between P0.1 M and P0.1 Pes was observed only during ventilation increased by CO 2 inhalation. Our patients who were breathing spontaneously were clinically stable after they recovered from an acute episode, and their airway flow resistance must have been substantially lower than that seen in acutely ill patients to cause an appreciable lag in transmission of changes in the alveolar pressure to the mouth, as shown in Table 1 .
Another potential limitation of the present study is the relatively low values of PEEPi, which may not be representative of patients with more severe hyperinflation. However, most studies conducted during exacerbation in patients with COPD have very rarely shown PEEPi values greater than 8 cm H 2 O, which makes the results of the present investigation generalizable to most clinical scenarios. Indeed, the limits of agreement between the two methods are not negligible when the mean recorded value is z1 cm H 2 O. In some patients, PEEPi ECHO may not always be reliable (as was found, for instance, in the case of patient number 11 with diaphragm dysfunction).
Lastly, there is another important aspect that needs to be underlined. The proposed technique requires specific engineering modifications of the ultrasound machine; however, combining flow and pressure tracings in the same device increases the utility of ultrasound in the critical-care setting.
In conclusion, in this preliminary physiological study, we have shown that in patients with COPD who are recovering from an acute exacerbation, the recording of PEEPi using ultrasound and P0.1 measurements is both feasible and reliable, and yields values comparable to those obtained by the more invasive gold standard technique. Further studies are needed to validate this technique on a larger scale with a wider range of PEEPi values. n
Volumetric Capnography for Noninvasive Monitoring of Acute Respiratory Distress Syndrome
To the Editor:
The severity of acute respiratory distress syndrome (ARDS) often increases during the first days of mechanical ventilation and may also develop in conjunction with mechanical ventilation for surgery (1, 2) . In patients with or in danger of ARDS, noninvasive monitoring of lung function reflecting ARDS evolution may be useful to indicate deterioration and the need for more active lung protection.
At all stages, efficient, noninvasive means for monitoring of ARDS evolution are needed for identification of those patients in whom enhanced lung protection is indicated.
Volumetric capnography permits bedside measurement of pulmonary dead space. Physiological dead-space fraction, VDphys/VT, is an independent risk factor for death in ARDS (3).
Determination of VDphys/VT requires determination of Pa CO 2 and that the blood gas analyzer and the capnograph have the same calibration. This limits the use of VDphys/VT. An efficiency index for CO 2 elimination (EFFi) was developed on the basis of a concept proposed by Fletcher and colleagues (4) and applied in healthy humans byÅström and colleagues (5) . The concept was modified with the goal of using all information of value in the volumetric capnogram, but excluding irrelevant information. Importantly, EFFi was calculated over a volume range reflecting predicted lung size of the individual subject. The hypothesis was tested that EFFi allows differentiation between healthy subjects and patients with ARDS with a spectrum of severity.
Methods
The subjects had been previously studied: 8 lung healthy subjects mechanically ventilated for elective intracranial surgery (6) and 11 patients with ARDS studied during mechanical ventilation (7) . The study in healthy subjects was approved by the Institutional Review Board of the Regional Ethics Committee in Lund, Sweden, and in ARDS by the Ethics Committee of the French Intensive Care Society. The patients were sedated and paralyzed and in steady state during recordings.
Volumetric capnography was based on flow and CO 2 signals from the sensors of the ServoVentilator 900C, including the CO 2 Analyzer 930 (Siemens-Elema), as described in the original studies (6, 7). The fast mainstream capnograph was attached to the y-piece connecting the ventilator to the tracheal tube. For calculation of EFFi, the analysis of the volumetric capnogram was limited to a standardized analyzed volume interval (VANA). VANA started at the appearance of CO 2 in the CO 2 sensor and ended after further expiration of 5 ml/kg predicted body weight (PBW). PBW was calculated from sex and height, in accordance with ARDS Network. EFFi was calculated as shown in Figure 1 . Arterial blood samples were taken for traditional calculation of physiological dead space, VDphys/VT, which was calculated according to the Enghoff modification of the Bohr equation.
Results
Capnograms at health and in ARDS differed systematically, as shown in Figure 2 , which is formatted to facilitate direct comparison between subjects or groups of subjects.
In ARDS, median EFFi was 0.68 (5th-95th percentile 0.48-0.75), compared with median 0.81 (5th-95th percentile 0.77-0.87) in healthy subjects. Ranges did not overlap, and the difference was significant (P , 0.0001).
Analysis of healthy and ARDS subjects together showed significant correlation between VDphys/VT and EFFi:
VDphys=VT ¼ 1:50 2 1:14 $ EFFi ðR ¼ 0:86; P , 0:001Þ
Discussion
In accordance with the hypothesis, EFFi clearly differentiated between healthy subjects and patients with ARDS. EFFi has several advantages over alternative parameters. EFFi is noninvasive and can be continuously monitored, and it is calculated over a defined volume interval related to PBW that reflects predicted lung size. Physiological dead space and other traditional capnographic parameters are highly dependent on volume; for example, VT. EFFi is not influenced by the volume of connectors and large airways. EFFi is dimensionless, and hence independent of calibration of the CO 2 sensor. EFFi directly reflects how efficient ventilation is with 
